Kuehn Law investigates Viking Therapeutics officers and directors for potential fiduciary breaches

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Kuehn Law, PLLC is investigating whether certain officers and directors of Viking Therapeutics, Inc. breached their fiduciary duties to shareholders. The shareholder litigation law firm is looking into potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. Long-term VKTX stockholders are encouraged to contact Justin Kuehn, Esq. for a free consultation.

Impact on assets 1

Biotech & Genomic Medicine▼
Viking Therapeutics Inc
VKTX
▼ NegativeRegulationrelevance

Investigation for potential fiduciary breaches and self-dealing by officers and directors